| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AFM
|
afamin
|
|
AHI1
|
Abelson helper integration site 1
|
|
ALB
|
albumin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOC2
|
apolipoprotein C-II
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QB
|
complement component 1, q subcomponent, B chain
|
|
C1QC
|
complement component 1, q subcomponent, C chain
|
|
CALB2
|
calbindin 2
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CASKIN1
|
CASK interacting protein 1
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CDC42
|
cell division cycle 42
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHGA
|
chromogranin A
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX7B
|
cytochrome c oxidase subunit VIIb
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
DAAM1
|
dishevelled associated activator of morphogenesis 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNMBP
|
dynamin binding protein
|
|
DSG1
|
desmoglein 1
|
|
DSG3
|
desmoglein 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4A2
|
eukaryotic translation initiation factor 4A2
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FDX1
|
ferredoxin 1
|
|
FDXR
|
ferredoxin reductase
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FOXO1
|
forkhead box O1
|
|
FTO
|
fat mass and obesity associated
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GFPT1
|
glutamine--fructose-6-phosphate transaminase 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HCCS
|
holocytochrome c synthase
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL6
|
interleukin 6
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
ISL1
|
ISL LIM homeobox 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LEP
|
leptin
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MC4R
|
melanocortin 4 receptor
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NRG1
|
neuregulin 1
|
|
NSMAF
|
neutral sphingomyelinase (N-SMase) activation associated factor
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OTULIN
|
OTU deubiquitinase with linear linkage specificity
|
|
PILRA
|
paired immunoglobin-like type 2 receptor alpha
|
|
PLAU
|
plasminogen activator, urokinase
|
|
POC5
|
POC5 centriolar protein
|
|
PON1
|
paraoxonase 1
|
|
PRSS50
|
protease, serine, 50
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
RET
|
ret proto-oncogene
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
RNF31
|
ring finger protein 31
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLN1
|
talin 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
UBC
|
ubiquitin C
|
|
UBD
|
ubiquitin D
|
|
UBE2L3
|
ubiquitin-conjugating enzyme E2L 3
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
